Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CARDINAL

Financiado

Cerrado

CARdiac tissue Design, beating INduction, and Assessment using multiwavelength L...

CARdiac tissue Design, beating INduction, and Assessment using multiwavelength Light (CARDINAL) Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Chronic treatments of CVDs are scarce because of poor predictivity of current two-dimensional (2D) pre-clinical models. State-of-the-art 3D-tissue models bas... ver más

31/10/2026

UNIPV

173K€

Presupuesto del proyecto: 173K€

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PAVIA No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-03

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIPV

172.75K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EMAPS-Cardio ElectroMechanoActive Polymer based Scaffolds for Heart on Ch... 5M€ Cerrado

MiniMI Generating a 3D Micro necroptosis induced Myocardial Infarct... Cerrado

3DVasCMD Development of novel 3D vascularized cardiac models to inves... 1M€ Cerrado

3DCardiacHTS Bringing 3D cardiac tissues to high throughput for drug disc... 1M€ Cerrado

EHT-CaMKII CaMKII over stimulation in engineered heart tissues EHTs m... 159K€ Cerrado

HEART2BEAT Advanced human models of the heart to understand cardiovascu... 3M€ Cerrado

Duración del proyecto: 29 meses Fecha Inicio: 2024-05-03
Fecha Fin: 2026-10-31

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PAVIA No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 173K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Chronic treatments of CVDs are scarce because of poor predictivity of current two-dimensional (2D) pre-clinical models. State-of-the-art 3D-tissue models based on human induced pluripotent stem cells (hiPSCs) can be more predictive of human genetics but fail to replicate the 3D cardiac muscle structure. In fact, the heart evolved to ensure efficient emptying of the chambers via a 3D chiral organization of muscle tissue not yet recapitulated in organoids or engineered ventricles. In CARdiac tissue Design, beating INduction, and Assessment using multiwavelength Light (CARDINAL), I will replicate the native chiral architecture of the heart in a minimal 3D model of the heart muscle and validate the resulting assay for drug screening. Our objectives will tackle three main challenges in the field: 1) Create the chiral scaffold to host the hiPSC-derived cardiac muscle cells (hiPSC-CMs). I will use cavitation molding - a light-based 3D-structuring method I previously developed - to obtain chirally organized micro-channels in soft hydrogels. 2) Populate these scaffolds with high-purity hiPSC-CMs that can be triggered and assayed with optical methods. I will leverage the host lab's engineered hiPSC line that features structural and functional fluorescent sensors. To that line, we will add optogenetic actuators and antibiotic resistance to directly control the final hiPSC-CM yield, trigger contraction, and image cell structure and function volumetrically. 3) Validate the predictivity of our new 3D chiral platform in drug screening applications. To do that, we will test a panel of cardiac drugs with known safety/efficacy profiles with our new platform, 2D hydrogels, and traditional glass slides. The CARDINAL project will provide the drug screening field with a more biomimetic tissue-engineered model of the heart muscle that can be extended to vascularized models and the full organ, eventually.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores